Badri, Prajakta http://orcid.org/0000-0003-1248-616X
Jiang, Xuemin
Borodovsky, Anna
Najafian, Nader
Kim, Jae
Clausen, Valerie A.
Goel, Varun
Habtemariam, Bahru
Robbie, Gabriel J.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
https://doi.org/10.1007/s40262-020-00940-9
Article History
First Online: 13 October 2020
Change Date: 17 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40262-022-01134-1
Declarations
:
: This work was supported by Alnylam Pharmaceuticals Inc., who contributed to the study design, research, and interpretation of data, and the writing, reviewing, and approval of the manuscript for publication.
: Prajakta Badri, Jae Kim, Xuemin Jiang, Anna Borodovsky, Nader Najafian, Valerie A. Clausen, Varun Goel, Bahru Habtemariam, and Gabriel J. Robbie are/were employees of Alnylam Pharmaceuticals Inc. and may hold Alnylam stocks or options.
: This study was conducted in accordance with the Good Clinical Practice Guideline as defined by the International Conference on Harmonisation, the Declaration of Helsinki, and all applicable federal and local regulations. The study was approved by independent Institutional Review Boards.
: Written informed consent was obtained from each subject before any study related procedures were performed.
: The authors, jointly and severally, give the Publisher the permission to publish the Work.
: The authors declare that [the/all other] data supporting the findings of this study are available within the article [and its supplementary information files].
: Not applicable.
: Written informed consent was obtained from each subject before any study-related procedures were performed.
: Prajakta Badri contributed to the data analyses for this manuscript, interpretation of results, writing and reviewing of the manuscript. Xuemin Jiang, Anna Borodovsky, Nader Najafian, Jae Kim, Valerie A. Clausen, Varun Goel, Bahru Habtemariam and Gabriel J. Robbie contributed to the study designs, interpretation of results, and writing and reviewing of the manuscript.